Trending/cancer drugs
Surrogate Endpoints Poor Proxy for Survival in Cancer Drug Approval Process
ROCHESTER, Minn. — Surrogate endpoints used to support the majority of new cancer drugs approved in the U.S. often lack formal study, according to the authors…
July 27, 2015
January 8, 2015
March 21, 2013
Special Topics
Sign up
Social Media Network
A network for digital healthcare communicators
Mayo Clinic Connect
An online patient support community